Bevan A P, Burgess J W, Drake P G, Shaver A, Bergeron J J, Posner B I
Polypeptide Hormone Laboratory, McGill University, Montreal, Quebec, Canada.
J Biol Chem. 1995 May 5;270(18):10784-91. doi: 10.1074/jbc.270.18.10784.
Insulin administration activates the insulin receptor kinase (IRK) in both plasma membrane (PM) and endosomes (ENs) raising the possibility of transmembrane signaling occurring in the endosomal compartment. Peroxovanadium compounds activate the IRK by inhibiting IR-associated phosphotyrosine phosphatase(s). Following the administration of the phosphotyrosine phosphatase inhibitor bisperoxo(1,10-phenanthroline)-oxovanadate (V) anion (bpV(phen)) activation of the hepatic IRK in ENs preceded that in PM by 5 min. When colchicine treatment preceded bpV(phen) administration IRK activation in ENs was unaffected but was totally abrogated in PM. Insulin receptor substrate-1 tyrosine phosphorylation followed the kinetics of IRK activation in ENs not PM and a hypoglycemic response similar to that achieved with a pharmacological dose of insulin ensued. These studies demonstrate that ENs constitute a site for IR-mediated signal transduction.
胰岛素给药可激活质膜(PM)和内体(ENs)中的胰岛素受体激酶(IRK),这增加了在内体区室中发生跨膜信号传导的可能性。过氧钒化合物通过抑制与IR相关的磷酸酪氨酸磷酸酶来激活IRK。在给予磷酸酪氨酸磷酸酶抑制剂双过氧(1,10-菲咯啉)-氧钒酸盐(V)阴离子(bpV(phen))后,肝脏内体中IRK的激活比质膜中的提前5分钟。当秋水仙碱处理先于bpV(phen)给药时,内体中的IRK激活不受影响,但质膜中的IRK激活则完全被消除。胰岛素受体底物-1酪氨酸磷酸化遵循内体而非质膜中IRK激活的动力学,并且随后出现了与药理剂量胰岛素所产生的相似的降血糖反应。这些研究表明,内体构成了IR介导的信号转导位点。